Products - Ear, nose and throat conditions | Topic | NICE

Showing 6 products

Date | Title

Status: In developmentRemove ‘Status: In development’ filter

Dupilumab for treating severe chronic rhinosinusitis with nasal polyps (review of TA648) [ID6480]
Status:
In development | In consultation
Programme:
Technology appraisal guidance
Consultation end date:
13 August 2025
Expected publication date:
29 October 2025
Benralizumab for previously treated severe nasal polyps [ID1659]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Topical rapamycin for treating facial angiofibromas associated with tuberous sclerosis complex in people 6 years and over [ID6391]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Corticosteroid-releasing bioabsorbable stent or spacer insertion during endoscopic sinus surgery to treat chronic rhinosinusitis
Status:
In development
Programme:
Interventional procedures guidance
Expected publication date:
TBC
Depemokimab for treating chronic rhinosinusitis with nasal polyps [ID6449]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Sirolimus gel for treating facial angiofibroma from tuberous sclerosis complex in people 6 years and older (review of TA972) [ID6440]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC